FDA Approved: GAVILYTE-N — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved the supplemental application for GAVILYTE-N, a polyethylene glycol-3350 with electrolytes laxative, manufactured by Lupin Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• GAVILYTE-N (POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE)

Snippet

SUPPL AP for GAVILYTE-N (POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE)